Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Kovas Co., Ltd.
483
•Kovas Co., Ltd.•November 22, 2019

Kovas Co., Ltd. – FDA 483, Nov 22, 2019

Record Details

An FDA inspection conducted at Kovas Co., Ltd., an Over-the-Counter (OTC) drug manufacturer in Paju, Gyeonggi, Republic of Korea, from November 18-22, 2019, resulted in 22 observations listed on Form FDA 483. These observations highlight significant deviations from Current Good Manufacturing Practices (cGMP) for drug products. Key issues identified primarily concern data integrity and laboratory controls. The firm failed to validate computerized systems like HPLC software, lacked appropriate controls to prevent unauthorized data modification or deletion, and did not maintain backup files for electronic data. Laboratory testing was found deficient, with issues including incorrect reference standards, absence of growth promotion testing for culture media, and inadequate microbial analysis methods. Further observations related to production and quality management. The stability testing program was not followed, equipment maintenance schedules were absent, and equipment use logs were not maintained. Documentation deficiencies included a lack of reserve samples for active ingredients, missing labeling samples in batch records, and the quality unit not adhering to its own procedures for change and document control. Notably, employees involved in production and quality control had not received routine cGMP training. Kovas Co., Ltd. is required to address these inspectional observations by implementing comprehensive corrective and preventive actions to ensure full compliance with regulatory standards for drug manufacturing.

Company
Kovas Co., Ltd.
Inspection date
November 22, 2019
Product type
drugs
Office
Office of Biological Products Operations - Division I
People
  • Yasamin Ameri (Compliance Officer)
  • Sook-Yang Ko (recipient)
View Company Profile

ID · 673e1c9c-42e7-411e-b53a-63f3b102f202

Other documents for Kovas Co., Ltd.
  • 483 - 2024-11-29November 29, 2024
  • EIR - 2024-11-29November 29, 2024
  • EIR - 2019-11-22November 22, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Kovas Co., Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.